Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
T cell apoptosis and reactive oxygen species
David A. Hildeman, Thomas Mitchell, John Kappler, Philippa Marrack
David A. Hildeman, Thomas Mitchell, John Kappler, Philippa Marrack
View: Text | PDF
Perspective

T cell apoptosis and reactive oxygen species

  • Text
  • PDF
Abstract

Authors

David A. Hildeman, Thomas Mitchell, John Kappler, Philippa Marrack

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Control of ACAD by ROS. TCR activation leads to increased mitochondrial ...
Control of ACAD by ROS. TCR activation leads to increased mitochondrial production of superoxide that is converted to H2O2 either via reactions with endogenous substrates (not shown) or via manganese superoxide dismutase (MnSOD). These ROS may have effects on various transcription factors, such as CREB, that may play a role in the downregulation of Bcl-2 and in subsequent sensitivity of T cells to the effects of ACAD.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts